The current SurePrint G3 Human Comparative Genomic Hybridization (CGH) platform has been extended to include a set of Single Nucleotide Polymorphism (SNP) probes on the same microarray. This allows ...
A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression profiling, and clinical research. By refining probe design and ...
Ottawa, Feb. 13, 2026 (GLOBE NEWSWIRE) -- The global single nucleotide polymorphism (SNP) genotyping market size is calculated at USD 8.08 billion in 2026 and is expected to reach around USD 19.48 ...
The surge in genomics and proteomics research for disease diagnosis, drug discovery, and personalized medicine is a primary driver of the DNA microarray market. Applications in Disease Diagnostics: ...
(MENAFN- GlobeNewsWire - Nasdaq) The global single nucleotide polymorphism (SNP) genotyping market size was valued at USD 7.24 billion in 2025 and is predicted to hit around USD 19.48 billion by 2034, ...